ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
38 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

ULURU Inc. (ULURU) is a pharmaceutical company that develops and commercializes wound care and muco-adhesive film products. The company offers products such as Altrazeal, Apthasol, OraDisc W, and others. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURUs Apthasol is used for treating aphthous ulcers in people with normal immune systems. The companys OraDisc is a polymer solid dosage form used to deliver amlexanox to the mucosal tissue. It also research and develops Nanoflex technology which is designed for optimizing the wound bed environment and accelerate healing. ULURU is headquartered in Addison, Texas, the US

ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the co

  
Source:
Document ID
GDPH13718D
Country
Industry
Ticker
ULUR=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
ULURU Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
ULURU Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
ULURU Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
ULURU Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
ULURU Inc., Medical Devices Deals, 2010 to YTD 201691
ULURU Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
ULURU Inc., Pharmaceuticals &Healthcare, Deal Details1124
  Partnerships111
    ULURU Partners with Saraya111
  Licensing Agreements121
    Uluru Expands Licensing Agreement with Altrazeal121
    Uluru Expands Licensing Agreement With Altrazeal131
    Uluru Expands Licensing Agreement With Altrazeal141
    ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal151
    ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa161
    ULURU Expands Licensing Agreement With Melmed For Altrazeal171
    Uluru Enters Into Licensing Agreement With Jiangxi Aiqilin Pharma181
  Equity Offering191
    Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants191
    Uluru to Raise USD1.6 Million in Private Placement of Shares201
    Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million211
    Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million221
    Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million232
    ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million252
    Uluru Completes Private Placement Of Preferred Shares For US$1 Million272
    ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million292
    ULURU Completes Registered Direct Offering Of Common Stock For US$1 Million312
  Debt Offering331
    Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million331
  Asset Transactions341
    Crawford Healthcare Acquires Zindaclin From ULURU And Strakan341
ULURU Inc. - Key Competitors351
Key Employees361
Locations And Subsidiaries371
  Head Office371
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ULURU-Inc-ULUR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13962>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). ULURU Inc. (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ULURU-Inc-ULUR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13962>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research